Latanoprost Cf

Latanoprost, the active ingredient in Latanoprost Cf, is a prostaglandin analog presented as a topical ophthalmic solution for ocular use. It lowers intraocular pressure and is employed in the management of open‑angle glaucoma and ocular hypertension in adult patients, typically under the direction of an ophthalmologist.

GNH USA supplies Latanoprost Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution.

Latanoprost is a prostaglandin analog used to lower intraocular pressure in glaucoma‑related conditions.

Open‑angle glaucoma: reduces intraocular pressure to slow disease progression. Ocular hypertension: lowers eye pressure to prevent development of glaucoma. Pseudoexfoliative glaucoma: decreases intraocular pressure to manage disease activity.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye irritation: burning or stinging sensation. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual increase in brown pigmentation.

Serious or Rare Side Effects: - Severe eye inflammation: uveitis or iritis requiring medical attention. - Allergic reaction: swelling, itching, or rash around the eye. - Corneal edema: swelling of the cornea that may affect vision.

When using Latanoprost, several precautions should be observed. - Monitor intraocular pressure: regular measurements to assess efficacy. - Assess for ocular infections: avoid use if active infection is present. - Avoid contact lens wear: discontinue lenses for at least 24 hours after instillation. - Inform ophthalmologist of other eye medications: potential additive effects. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analog eye drops: may cause excessive pressure reduction. - Use with ocular anesthetic drops: increased risk of corneal irritation.

Moderate Interactions (Monitor Closely): - Combination with beta‑blocker eye drops: additive intraocular pressure‑lowering effect. - Co‑administration with alpha‑agonist eye drops: may alter efficacy. - Systemic carbonic anhydrase inhibitors: potential pharmacodynamic interaction.